OraSure Technologies Appoints Vice President, Consumer Marketing
18 Luglio 2007 - 12:00PM
Business Wire
OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral
fluid diagnostics, today announced that Kenneth A. Adach will be
appointed as the Company�s Vice President, Consumer Marketing. Mr.
Adach joins OraSure with extensive experience in consumer sales and
marketing, including over twenty-five years of relevant
over-the-counter (�OTC�) marketing experience. Since 2005, Mr.
Adach has served as Director of Marketing for Bausch & Lomb�s
highly successful line of OTC pharmaceutical products. From 1989 to
2005, Mr. Adach held senior marketing positions at Playtex
Products, Inc., serving as Director of Marketing for feminine care
and infant feeding products, and at Lehn & Fink, where he had
marketing responsibility for the Minwax line of paints and stains.
Earlier in his career, Mr. Adach served in various marketing
positions at Unilever and the Lipton Tea Company. Mr. Adach
received an MBA degree from Rutgers University and a B.S. degree in
Marketing from the University of South Carolina. �We are extremely
pleased that Kenn has agreed to join OraSure and head up our
consumer marketing efforts,� said Douglas A. Michels, President and
CEO of OraSure Technologies. �We continue to make good progress in
the clinical studies that will support our application for FDA
approval of our OraQuick ADVANCE� Rapid HIV-1/2 Antibody Test for
use in the United States OTC market. Kenn�s primary responsibility
will be to lead the effort to commercialize this product once FDA
approval is obtained. With his consumer marketing background, we
expect Kenn to be a valuable contributor for the Company.� About
OraSure Technologies OraSure Technologies develops, manufactures
and markets oral fluid specimen collection devices using
proprietary oral fluid technologies, diagnostic products including
immunoassays and other in vitro diagnostic tests, and other medical
devices. These products are sold in the United States as well as
internationally to various clinical laboratories, hospitals,
clinics, community-based organizations and other public health
organizations, distributors, government agencies, physicians�
offices, and commercial and industrial entities. OraSure
Technologies is the leading supplier of oral-fluid collection
devices and in vitro diagnostic assays to the employment, criminal
justice, drug treatment, life insurance and public health markets
for the detection of abused drugs and the antibodies to HIV. Based
in Bethlehem, Pa., the company develops, manufactures and markets
oral specimen collection devices, in vitro diagnostic tests, and
other medical devices. For more information on the Company, please
go to www.orasure.com.
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Lug 2023 a Lug 2024